Accelerating clinical development with integrated digital patient analytics

We create unique Digital Patient Profiles to simulate ‘what if’ scenarios in clinical development processes and decision making using AI-driven patient-centric data analytics. Leveraging the most comprehensive contextualised data platform to deliver unmatched insight, precision and certainty.

Smarter trials, faster cures. Delivered.

Request a demo to access the data for your indication
What we do

Powered by the world’s largest clinical trials database, Phesi’s AI-driven solutions enable life sciences companies to accelerate drug development and commercialization. Turn real world clinical trial data into insights and answers with our Trial Accelerator™ platform generating Digital Patient Profiles, Digital Twins and Digital Trial Arms. Smarter trials, faster cures. Delivered.

What makes Phesi different

Data-driven clinical development

Real-world patient-centric data analytic solutions, trusted by the world’s leading pharmaceutical companies.

Optimizing program and protocol design by creating Digital Patient Profiles, Digital Twins and Digital Trial Arms, we can help you improve patient population accuracy and diversity, reduce trial timelines and patient burden, across every stage of clinical development for any indication, including rare diseases. 

The power behind every successful trial.

Read more

World’s largest clinical trials database containing real-world data

Trial Accelerator Platform enables predictive modelling in 4 key views: Patient Profile, Trial Performance, Country, Investigator Site

Digital Twin and Digital Trial Arm services generate reliable evidence without the expense or time needed in traditional trials

Powered by the Phesi proprietary integrated methodology and ground-breaking AI technologies

485 k

Curated clinical trials

4.2 m

Physicians

90 k

Updated data sources

70 m+

Patients

4000 +

Disease indications

our clients

Customer experience

Phesi is on the frontiers of defining clinical development as a science, performing systematic analysis of the clinical trial, clinical protocol, and clinical site space to form hypotheses about what will work and what will not. Through observation and experiment you are applying those learnings to inform new clinical programs or save old ones. Phesi is more than the sum of its parts and the value is in the integration.

FORMER SVP, GLOBAL CHIEF MEDICAL OFFICER AND US R&D HEAD Sanofi

Every global R&D leader should know about this and should be testing it within their portfolio.

senior director, clinical operations Takeda

Phesi worked with us to show that a particular adaptive trial design would give the best performance. The result was a significantly quicker and cheaper devel­opment time on this priority asset.

senior director, clinical operations Takeda
News & events
06. 10. 2024
Global oncology trial investigator sites increase by half in five years, finds new Phesi analysis Read more
05. 14. 2024
Phesi launches predictive Patient Burden Score to improve trial efficiency, patient experience and investigator site performance Read more
05. 08. 2024
Phesi Q1 2024 Business Update Read more
02. 12. 2024
Phesi announces AI-driven Trial Accelerator™ hits critical milestone with data from 100 million patients Read more
01. 16. 2024
Phesi releases 2023 analysis of clinical development; breast cancer remains most studied disease area for third year Read more
10. 15. 2023
Phesi launches Health Check and Trial Rescue Service to save at-risk trials and bring drugs to market faster Read more